Login / Signup

Post-translational covalent assembly of CAR and synNotch receptors for programmable antigen targeting.

Elisa RuffoAdam A ButchyYaniv TivonVictor SoMichael KvorjakAvani B ParikhEric L AdamsNatasa Miskov-ZivanovOlivera J FinnAlexander DeitersJason Lohmueller
Published in: Nature communications (2023)
Chimeric antigen receptors (CARs) and synthetic Notch (synNotch) receptors are engineered cell-surface receptors that sense a target antigen and respond by activating T cell receptor signaling or a customized gene program, respectively. Here, to expand the targeting capabilities of these receptors, we develop "universal" receptor systems for which receptor specificity can be directed post-translationally via covalent attachment of a co-administered antibody bearing a benzylguanine (BG) motif. A SNAPtag self-labeling enzyme is genetically fused to the receptor and reacts with BG-conjugated antibodies for covalent assembly, programming antigen recognition. We demonstrate that activation of SNAP-CAR and SNAP-synNotch receptors can be successfully targeted by clinically relevant BG-conjugated antibodies, including anti-tumor activity of SNAP-CAR T cells in vivo in a human tumor xenograft mouse model. Finally, we develop a mathematical model to better define the parameters affecting universal receptor signaling. SNAP receptors provide a powerful strategy to post-translationally reprogram the targeting specificity of engineered cells.
Keyphrases
  • mouse model
  • cancer therapy
  • cell surface
  • gene expression
  • endothelial cells
  • mesenchymal stem cells
  • stem cells
  • photodynamic therapy
  • genome wide
  • dna methylation
  • drug delivery
  • bone marrow